Stantec (STN) Financials

$107.99 +1.27 (+1.19%)

Closing price 06/16/2025 03:59 PM Eastern

Extended Trading

$108.00 +0.01 (+0.01%)

As of 06/16/2025 07:41 PM Eastern

Annual Income Statements for Stantec

This table shows Stantec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	60	-2,971	35	150	134	157	183	240	251
Consolidated Net Income / (Loss)	97	77	35	150	134	157	183	240	251
Net Income / (Loss) Continuing Operations	60	-2,971	126	150	125	157	183	240	251
Total Pre-Tax Income	135	-2,971	126	150	125	206	183	309	323
Total Operating Income	122	-2,991	152	221	168	243	237	272	294
Total Gross Profit	1,247	-1,780	1,330	1,548	1,513	1,537	1,786	3,730	3,972
Total Revenue	3,191	21	3,139	3,677	3,725	3,586	4,227	4,801	5,107
Operating Revenue	3,191	21	3,139	3,677	3,725	3,586	4,227	4,801	5,107
Total Cost of Revenue	1,981	1,801	1,849	2,172	2,257	2,045	2,499	1,071	1,134
Operating Cost of Revenue	1,981	1,801	1,849	2,172	2,257	2,045	2,499	1,071	1,134
Total Operating Expenses	1,088	1,210	1,138	1,284	1,300	1,294	1,492	3,458	3,678
Selling, General & Admin Expense	994	1,119	1,054	1,105	1,061	1,114	1,288	1,489	1,588
Depreciation Expense	38	41	37	134	138	127	132	138	135
Amortization Expense	56	58	48	52	42	47	77	77	86
Other Operating Expenses / (Income)	0.15	-7.95	0.07	-8.48	-1.65	-13	-5.17	1,755	1,845
Impairment Charge	-	-	-	1.54	62	19	-	0.23	24
Total Other Income / (Expense), net	-25	19	-26	-71	-44	-37	-54	-32	-43
Interest Expense	21	21	21	54	39	30	54	70	73
Other Income / (Expense), net	-3.50	-3.34	-4.98	-18	-5.02	-7.36	-	38	29
Weighted Average Basic Shares Outstanding	1.22	0.00	111.86M	111.21M	111.01M	111.33M	110.81M	111.23M	114.07M
Weighted Average Diluted Shares Outstanding	-	0.00	111.86M	111.21M	111.01M	111.33M	110.81M	111.23M	114.07M
Weighted Average Basic & Diluted Shares Outstanding	-	0.00	111.86M	111.21M	111.01M	111.33M	110.81M	222.46M	228.13M

No quarterly income statements for Stantec are available.

This table details how cash moves in and out of Stantec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	3,226	23	3,172	3,773	261	-29	18	155	-86
Net Cash From Operating Activities	0.00	3,366	2.71	2.23	63	16	62	394	419
Net Cash From Continuing Operating Activities	0.00	3,366	2.71	2.23	63	16	62	323	323
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	240	251
Consolidated Net Income / (Loss)	-	-	-	-	-	-	-	240	251
Depreciation Expense	-	-	-	-	45	42	42	138	135
Non-Cash Adjustments To Reconcile Net Income	-	3,589	2.71	2.23	28	-46	-90	62	74
Changes in Operating Assets and Liabilities, net	-	15	-	-	-51	-28	33	-117	-138
Net Cash From Investing Activities	3,318	-47	3,200	3,803	0.00	0.00	0.00	-153	-420
Net Cash From Continuing Investing Activities	3,318	-47	3,200	3,803	0.00	0.00	0.00	-153	-420
Acquisitions	-	-	-	-	-	-	-	-57	-385
Purchase of Investments	-	-	-	-	-	-	-	-160	-97
Sale and/or Maturity of Investments	-	-	-	-	-	-	-	55	51
Other Investing Activities, net	3,318	-	3,200	3,803	-	-	-	9.17	11
Net Cash From Financing Activities	-92	-219	-31	-31	197	-45	-45	-83	-106
Net Cash From Continuing Financing Activities	-92	-219	-31	-31	197	-45	-45	-30	-30
Repayment of Debt	-93	0.00	-31	-31	-36	-45	-45	-439	35
Payment of Dividends	0.60	44	-	-	-	-	-	-64	-65
Issuance of Debt	-	163	-	0.00	234	-	0.00	264	0.00
Issuance of Common Equity	-	11	-	-	-	-	-	210	0.00
Other Financing Activities, net	-	-	-	-	-	-	-	-0.53	0.00

No quarterly cash flow statements for Stantec are available.

This table presents Stantec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	1/1/2023	12/31/2023	12/31/2024
Total Assets	3,189	3,086	2,938	3,515	3,440	4,090	3,946	4,368	4,831
Total Current Assets	1,178	1,278	1,198	1,218	1,227	1,303	1,432	1,721	1,770
Cash & Equivalents	157	197	136	172	227	152	110	267	159
Accounts Receivable	600	978	643	630	579	645	1,169	1,278	1,422
Prepaid Expenses	46	43	42	33	31	36	36	41	45
Current Deferred & Refundable Income Taxes	35	49	35	28	37	67	48	55	45
Plant, Property, & Equipment, net	159	-17	212	221	188	183	-36	-39	-46
Plant, Property & Equipment, gross	159	-17	212	221	188	183	-36	-39	-46
Total Noncurrent Assets	1,852	1,819	1,528	2,077	2,025	2,605	2,583	2,727	3,160
Goodwill	1,360	1,237	1,188	1,273	1,312	1,710	1,502	1,571	1,884
Intangible Assets	335	209	182	169	143	292	237	201	297
Noncurrent Deferred & Refundable Income Taxes	19	18	16	25	33	38	33	70	83
Other Noncurrent Operating Assets	130	346	136	610	537	565	811	885	897
Total Liabilities & Shareholders' Equity	3,189	3,086	2,938	3,515	3,440	4,090	3,946	4,368	4,831
Total Liabilities	1,718	1,576	1,540	2,069	1,928	2,523	2,474	2,511	2,785
Total Current Liabilities	798	718	655	776	774	923	841	955	1,079
Accounts Payable	534	560	416	444	452	497	580	638	707
Current Deferred Revenue	150	149	-	-	-	-	242	301	349
Current Deferred & Payable Income Tax Liabilities	1.34	8.74	28	22	19	21	19	16	22
Total Noncurrent Liabilities	919	837	885	1,293	1,154	1,600	1,597	1,517	1,661
Long-Term Debt	691	588	649	627	497	935	921	850	973
Capital Lease Obligations	-	-	0.00	454	412	427	73	77	79
Noncurrent Deferred & Payable Income Tax Liabilities	59	43	51	65	58	68	26	20	44
Noncurrent Employee Benefit Liabilities	38	36	50	66	71	46	24	22	16
Other Noncurrent Operating Liabilities	131	170	135	81	115	126	553	548	549
Total Equity & Noncontrolling Interests	1,471	2,999	1,399	1,447	1,512	1,567	1,472	1,857	2,045
Total Preferred & Common Equity	1,470	2,997	1,397	1,445	1,512	1,567	0.00	0.00	0.00
Total Common Equity	1,470	2,997	1,397	1,445	1,512	1,567	0.00	0.00	0.00
Noncontrolling Interest	0.60	2.38	1.32	1.23	0.63	0.39	1,472	1,857	2,045

No quarterly balance sheets for Stantec are available.

This table displays calculated financial ratios and metrics derived from Stantec's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-99.34%	14,860.76%	17.15%	1.31%	-3.75%	17.90%	13.57%	6.37%
EBITDA Growth	0.00%	-1,459.99%	107.98%	68.52%	-35.65%	29.66%	9.63%	25.80%	2.48%
EBIT Growth	0.00%	-2,628.76%	104.90%	38.83%	-19.74%	44.22%	0.48%	31.09%	4.31%
NOPAT Growth	0.00%	-2,479.39%	107.24%	45.91%	-23.88%	10.12%	27.68%	14.95%	8.12%
Net Income Growth	0.00%	-20.62%	-54.94%	331.34%	-10.47%	17.11%	16.20%	31.34%	4.72%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	0.00%	0.00%	-99.92%	-17.57%	2,734.05%	-74.79%	290.64%	531.51%	6.33%
Free Cash Flow Firm Growth	0.00%	0.00%	117.24%	-157.49%	237.73%	-209.48%	132.12%	241.93%	-134.58%
Invested Capital Growth	0.00%	9.58%	-12.54%	26.83%	-6.66%	26.63%	5.16%	-3.78%	16.79%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	39.10%	-8,486.36%	42.38%	42.09%	40.63%	42.86%	42.26%	77.70%	77.79%
EBITDA Margin	6.67%	-13,796.59%	7.36%	10.58%	6.72%	9.05%	8.42%	9.33%	8.98%
Operating Margin	3.82%	-14,254.92%	4.83%	6.01%	4.52%	6.77%	5.60%	5.67%	5.76%
EBIT Margin	3.71%	-14,270.83%	4.67%	5.53%	4.38%	6.57%	5.60%	6.46%	6.34%
Profit (Net Income) Margin	3.04%	367.42%	1.11%	4.07%	3.60%	4.38%	4.32%	4.99%	4.92%
Tax Burden Percent	72.18%	-2.59%	27.67%	100.00%	107.54%	76.31%	100.00%	77.63%	77.69%
Interest Burden Percent	113.64%	99.24%	85.65%	73.64%	76.38%	87.40%	77.14%	99.56%	99.87%
Effective Tax Rate	27.82%	0.00%	0.00%	0.00%	0.00%	23.69%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	5.08%	-115.44%	8.53%	11.76%	8.28%	8.33%	9.28%	10.60%	10.79%
ROIC Less NNEP Spread (ROIC-NNEP)	8.60%	-630.21%	36.23%	-3.80%	2.11%	4.21%	3.41%	6.53%	5.24%
Return on Net Nonoperating Assets (RNNOA)	1.52%	118.89%	-6.95%	-1.22%	0.79%	1.87%	1.93%	3.11%	2.08%
Return on Equity (ROE)	6.60%	3.45%	1.58%	10.53%	9.07%	10.20%	11.21%	13.71%	12.87%
Cash Return on Invested Capital (CROIC)	0.00%	-124.59%	21.91%	-11.90%	15.16%	-15.17%	4.25%	14.45%	-4.70%
Operating Return on Assets (OROA)	3.71%	-95.44%	4.87%	6.31%	4.69%	6.25%	5.72%	7.46%	7.03%
Return on Assets (ROA)	3.05%	2.46%	1.15%	4.64%	3.86%	4.17%	4.42%	5.77%	5.46%
Return on Common Equity (ROCE)	6.60%	3.45%	1.58%	10.52%	9.06%	10.20%	5.39%	0.00%	0.00%
Return on Equity Simple (ROE_SIMPLE)	6.61%	2.57%	2.49%	10.37%	8.87%	10.03%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	88	-2,093	152	221	168	185	237	272	294
NOPAT Margin	2.76%	-9,978.45%	4.83%	6.01%	4.52%	5.17%	5.60%	5.67%	5.76%
Net Nonoperating Expense Percent (NNEP)	-3.52%	514.77%	-27.71%	15.56%	6.17%	4.12%	5.87%	4.07%	5.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.77%	9.50%
Cost of Revenue to Revenue	62.08%	8,586.36%	58.91%	59.08%	60.59%	57.05%	59.11%	22.30%	22.21%
SG&A Expenses to Revenue	31.14%	5,332.20%	33.58%	30.05%	28.47%	31.07%	30.46%	31.01%	31.09%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	34.10%	5,768.56%	36.27%	34.91%	34.89%	36.08%	35.29%	72.03%	72.03%
Earnings before Interest and Taxes (EBIT)	118	-2,994	147	203	163	236	237	310	324
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	213	-2,894	231	389	250	325	356	448	459
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	2.08	2.31	3.90	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	953.37	61.26	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.82	0.94	1.70	1.25	1.84	1.75
Price to Earnings (P/E)	0.00	0.00	0.00	20.11	26.03	38.86	28.93	36.79	35.65
Dividend Yield	1.97%	1.95%	2.69%	2.15%	1.98%	1.20%	1.52%	0.98%	0.85%
Earnings Yield	0.00%	0.00%	0.00%	4.97%	3.84%	2.57%	3.46%	2.72%	2.81%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.88	2.14	2.96	3.02	4.51	4.05
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	1.08	1.13	2.05	1.87	2.36	2.33
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	10.17	16.82	22.65	22.18	25.32	25.91
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	19.46	25.79	31.23	33.36	36.55	36.74
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	17.90	25.02	39.68	33.36	41.67	40.42
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	1,771.32	66.48	460.59	126.58	28.78	28.38
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	13.66	0.00	72.82	30.58	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.52	0.20	0.49	0.77	0.63	0.89	0.61	0.50	0.51
Long-Term Debt to Equity	0.47	0.20	0.46	0.75	0.60	0.87	0.61	0.50	0.51
Financial Leverage	0.18	-0.19	-0.19	0.32	0.37	0.45	0.57	0.48	0.40
Leverage Ratio	2.17	1.40	1.37	2.27	2.35	2.45	2.54	2.50	2.36
Compound Leverage Factor	2.46	1.39	1.17	1.67	1.80	2.14	1.96	2.49	2.35
Debt to Total Capital	34.05%	16.39%	32.85%	43.58%	38.48%	47.20%	37.98%	33.29%	33.96%
Short-Term Debt to Total Capital	3.07%	0.00%	1.71%	1.41%	1.49%	1.34%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	30.98%	16.39%	31.14%	42.17%	37.00%	45.86%	37.98%	33.29%	33.96%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.07%	0.06%	0.05%	0.03%	0.01%	62.02%	66.71%	66.04%
Common Equity to Total Capital	65.92%	83.55%	67.09%	56.37%	61.49%	52.78%	0.00%	0.00%	0.00%
Debt to EBITDA	3.57	-0.20	2.96	2.87	3.78	4.32	2.91	2.07	2.29
Net Debt to EBITDA	2.77	-0.13	2.35	2.43	2.87	3.85	2.60	1.47	1.95
Long-Term Debt to EBITDA	3.25	-0.20	2.81	2.78	3.63	4.19	2.91	2.07	2.29
Debt to NOPAT	8.63	-0.28	4.52	5.05	5.62	7.56	4.37	3.41	3.58
Net Debt to NOPAT	6.70	-0.18	3.57	4.27	4.27	6.74	3.91	2.42	3.04
Long-Term Debt to NOPAT	7.85	-0.28	4.28	4.89	5.40	7.34	4.37	3.41	3.58
Altman Z-Score	0.00	0.00	0.00	2.54	2.79	2.91	2.65	3.65	3.38
Noncontrolling Interest Sharing Ratio	0.04%	0.07%	0.08%	0.09%	0.06%	0.03%	51.89%	100.00%	100.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.48	1.78	1.83	1.57	1.59	1.41	1.75	1.80	1.64
Quick Ratio	0.95	1.64	1.26	1.10	1.11	0.92	1.56	1.62	1.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-2,259	389	-224	308	-338	108	371	-128
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	-109.77	18.52	-4.17	7.99	-11.38	2.00	5.26	-1.77
Operating Cash Flow to Interest Expense	0.00	163.53	0.13	0.04	1.64	0.54	1.15	5.59	5.78
Operating Cash Flow Less CapEx to Interest Expense	0.00	165.81	0.13	0.04	1.64	0.54	1.15	5.59	5.78
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	1.00	0.01	1.04	1.14	1.07	0.95	1.02	1.16	1.11
Accounts Receivable Turnover	5.32	0.03	3.87	5.77	6.16	5.86	4.66	3.92	3.78
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	20.04	0.00	0.00	16.99	18.22	19.32	0.00	0.00	0.00
Accounts Payable Turnover	3.71	3.29	3.79	5.05	5.04	4.31	4.74	1.76	1.69
Days Sales Outstanding (DSO)	68.65	13,729.23	94.29	63.21	59.22	62.26	78.28	93.01	96.51
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	98.48	110.87	96.30	72.23	72.43	84.61	77.07	207.63	216.48
Cash Conversion Cycle (CCC)	-29.83	13,618.37	-2.01	-9.02	-13.22	-22.35	1.21	-114.62	-119.98
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	1,730	1,896	1,658	2,103	1,963	2,486	2,614	2,516	2,938
Invested Capital Turnover	1.84	0.01	1.77	1.96	1.83	1.61	1.66	1.87	1.87
Increase / (Decrease) in Invested Capital	0.00	166	-238	445	-140	523	128	-99	422
Enterprise Value (EV)	0.00	0.00	0.00	3,959	4,211	7,354	7,895	11,336	11,887
Market Capitalization	0.00	0.00	0.00	3,012	3,491	6,104	5,280	8,820	8,949
Book Value per Share	$1,205,118,530.33	$3,525,676,758.82	$12.49	$12.92	$13.59	$14.11	$0.00	$0.00	$0.00
Tangible Book Value per Share	($184,150,065.57)	$1,825,057,303.53	$0.25	$0.03	$0.51	($3.92)	($17.70)	($15.99)	($19.11)
Total Capital	2,230	3,587	2,083	2,564	2,459	2,968	2,724	2,783	3,097
Total Debt	759	588	684	1,117	946	1,401	1,035	926	1,052
Total Long-Term Debt	691	588	649	1,081	910	1,361	1,035	926	1,052
Net Debt	589	382	542	945	719	1,249	925	659	893
Capital Expenditures (CapEx)	0.00	-47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	284	364	443	306	263	268	503	499	533
Debt-free Net Working Capital (DFNWC)	448	560	579	478	490	420	612	766	691
Net Working Capital (NWC)	379	560	544	442	453	380	612	766	691
Net Nonoperating Expense (NNE)	-9.13	-2,171	117	71	34	28	54	32	43
Net Nonoperating Obligations (NNO)	260	-1,103	260	657	451	919	925	659	893
Total Depreciation and Amortization (D&A)	94	99	84	186	87	89	119	138	135
Debt-free, Cash-free Net Working Capital to Revenue	8.91%	1,734.09%	14.13%	8.32%	7.05%	7.47%	11.89%	10.39%	10.43%
Debt-free Net Working Capital to Revenue	14.03%	2,671.21%	18.45%	13.01%	13.14%	11.70%	14.48%	15.95%	13.54%
Net Working Capital to Revenue	11.89%	2,671.21%	17.32%	12.03%	12.16%	10.59%	14.48%	15.95%	13.54%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$1.74	$0.00	$1.80	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	1.00	0.00	111.21M	111.01M	111.33M	110.81M	114.07M	114.07M
Adjusted Diluted Earnings per Share	$0.00	$0.85	$0.00	$1.74	$0.00	$1.80	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	111.21M	111.01M	111.33M	110.81M	114.07M	114.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$1.74	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	111.21M	111.01M	111.33M	110.81M	114.07M	228.13M
Normalized Net Operating Profit after Tax (NOPAT)	88	-2,093	106	156	161	200	166	191	223
Normalized NOPAT Margin	2.76%	-9,978.45%	3.38%	4.24%	4.32%	5.58%	3.92%	3.97%	4.36%
Pre Tax Income Margin	4.22%	-14,162.12%	4.00%	4.07%	3.35%	5.74%	4.32%	6.43%	6.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.56	-145.46	6.97	3.79	4.23	7.94	4.37	4.40	4.46
NOPAT to Interest Expense	4.13	-101.71	7.21	4.12	4.36	6.25	4.37	3.86	4.06
EBIT Less CapEx to Interest Expense	5.56	-143.19	6.97	3.79	4.23	7.94	4.37	4.40	4.46
NOPAT Less CapEx to Interest Expense	4.13	-99.44	7.21	4.12	4.36	6.25	4.37	3.86	4.06
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-0.61%	-57.22%	0.00%	0.00%	0.00%	0.00%	0.00%	26.82%	26.00%
Augmented Payout Ratio	-0.61%	-57.22%	0.00%	0.00%	0.00%	0.00%	0.00%	26.82%	26.00%

No quarterly metrics and ratios for Stantec are available.

Frequently Asked Questions About Stantec's Financials

When does Stantec's financial year end?

According to the most recent income statement we have on file, Stantec's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Stantec's net income changed over the last 8 years?

Stantec's net income appears to be on an upward trend, with a most recent value of $251.04 million in 2024, rising from $97.11 million in 2016. The previous period was $239.74 million in 2023. See where experts think Stantec is headed by visiting Stantec's forecast page.

What is Stantec's operating income?

Stantec's total operating income in 2024 was $294.10 million, based on the following breakdown:

Total Gross Profit: $3.97 billion
Total Operating Expenses: $3.68 billion

How has Stantec's revenue changed over the last 8 years?

Over the last 8 years, Stantec's total revenue changed from $3.19 billion in 2016 to $5.11 billion in 2024, a change of 60.1%.

How much debt does Stantec have?

Stantec's total liabilities were at $2.79 billion at the end of 2024, a 10.9% increase from 2023, and a 62.2% increase since 2016.

How much cash does Stantec have?

In the past 8 years, Stantec's cash and equivalents has ranged from $109.59 million in 2022 to $267.31 million in 2023, and is currently $158.68 million as of their latest financial filing in 2024.

How has Stantec's book value per share changed over the last 8 years?

Over the last 8 years, Stantec's book value per share changed from 1,205,118,530.33 in 2016 to 0.00 in 2024, a change of -100.0%.

Related Companies

This page (NYSE:STN) was last updated on 6/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stantec (STN) Financials

Frequently Asked Questions About Stantec's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stantec (STN) Financials

Annual Income Statements for Stantec

Quarterly Income Statements for Stantec

Annual Cash Flow Statements for Stantec

Quarterly Cash Flow Statements for Stantec

Annual Balance Sheets for Stantec

Quarterly Balance Sheets for Stantec

Annual Metrics And Ratios for Stantec

Quarterly Metrics And Ratios for Stantec

Frequently Asked Questions About Stantec's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools